nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—Constipation—Gemcitabine—lung cancer	0.000606	0.000681	CcSEcCtD
Frovatriptan—Nausea—Erlotinib—lung cancer	0.000606	0.000681	CcSEcCtD
Frovatriptan—Dry mouth—Paclitaxel—lung cancer	0.000606	0.00068	CcSEcCtD
Frovatriptan—Anaphylactic shock—Etoposide—lung cancer	0.000606	0.00068	CcSEcCtD
Frovatriptan—Mood swings—Doxorubicin—lung cancer	0.000605	0.00068	CcSEcCtD
Frovatriptan—Diarrhoea—Vinorelbine—lung cancer	0.000604	0.000678	CcSEcCtD
Frovatriptan—Dysgeusia—Docetaxel—lung cancer	0.000604	0.000678	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000602	0.000676	CcSEcCtD
Frovatriptan—Ataxia—Doxorubicin—lung cancer	0.000601	0.000675	CcSEcCtD
Frovatriptan—Feeling abnormal—Irinotecan—lung cancer	0.0006	0.000674	CcSEcCtD
Frovatriptan—Confusional state—Paclitaxel—lung cancer	0.000599	0.000672	CcSEcCtD
Frovatriptan—Back pain—Docetaxel—lung cancer	0.000596	0.00067	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Irinotecan—lung cancer	0.000595	0.000668	CcSEcCtD
Frovatriptan—Dehydration—Doxorubicin—lung cancer	0.000594	0.000667	CcSEcCtD
Frovatriptan—Anaphylactic shock—Paclitaxel—lung cancer	0.000594	0.000667	CcSEcCtD
Frovatriptan—Paraesthesia—Cisplatin—lung cancer	0.000594	0.000667	CcSEcCtD
Frovatriptan—Muscle spasms—Docetaxel—lung cancer	0.000593	0.000666	CcSEcCtD
Frovatriptan—Tachycardia—Etoposide—lung cancer	0.000591	0.000664	CcSEcCtD
Frovatriptan—Dyspnoea—Cisplatin—lung cancer	0.000589	0.000662	CcSEcCtD
Frovatriptan—Hyperhidrosis—Etoposide—lung cancer	0.000585	0.000657	CcSEcCtD
Frovatriptan—Feeling abnormal—Gemcitabine—lung cancer	0.000584	0.000656	CcSEcCtD
Frovatriptan—Shock—Paclitaxel—lung cancer	0.000584	0.000656	CcSEcCtD
Frovatriptan—Dizziness—Vinorelbine—lung cancer	0.000584	0.000655	CcSEcCtD
Frovatriptan—Tachycardia—Paclitaxel—lung cancer	0.000579	0.000651	CcSEcCtD
Frovatriptan—Anorexia—Etoposide—lung cancer	0.000577	0.000648	CcSEcCtD
Frovatriptan—Abdominal pain—Irinotecan—lung cancer	0.000576	0.000646	CcSEcCtD
Frovatriptan—Body temperature increased—Irinotecan—lung cancer	0.000576	0.000646	CcSEcCtD
Frovatriptan—Decreased appetite—Cisplatin—lung cancer	0.000575	0.000645	CcSEcCtD
Frovatriptan—Hyperhidrosis—Paclitaxel—lung cancer	0.000574	0.000645	CcSEcCtD
Frovatriptan—Depression—Methotrexate—lung cancer	0.000567	0.000637	CcSEcCtD
Frovatriptan—Anorexia—Paclitaxel—lung cancer	0.000566	0.000636	CcSEcCtD
Frovatriptan—Pain—Cisplatin—lung cancer	0.000565	0.000635	CcSEcCtD
Frovatriptan—Muscular weakness—Doxorubicin—lung cancer	0.000564	0.000633	CcSEcCtD
Frovatriptan—Vomiting—Vinorelbine—lung cancer	0.000561	0.00063	CcSEcCtD
Frovatriptan—Body temperature increased—Gemcitabine—lung cancer	0.000561	0.00063	CcSEcCtD
Frovatriptan—Stomatitis—Methotrexate—lung cancer	0.000554	0.000623	CcSEcCtD
Frovatriptan—Headache—Vinorelbine—lung cancer	0.000553	0.000621	CcSEcCtD
Frovatriptan—Syncope—Docetaxel—lung cancer	0.000553	0.000621	CcSEcCtD
Frovatriptan—Conjunctivitis—Methotrexate—lung cancer	0.000553	0.000621	CcSEcCtD
Frovatriptan—Dysphagia—Doxorubicin—lung cancer	0.000552	0.00062	CcSEcCtD
Frovatriptan—Palpitations—Docetaxel—lung cancer	0.000545	0.000612	CcSEcCtD
Frovatriptan—Feeling abnormal—Cisplatin—lung cancer	0.000545	0.000612	CcSEcCtD
Frovatriptan—Paraesthesia—Etoposide—lung cancer	0.000544	0.000611	CcSEcCtD
Frovatriptan—Loss of consciousness—Docetaxel—lung cancer	0.000542	0.000609	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000541	0.000607	CcSEcCtD
Frovatriptan—Dyspnoea—Etoposide—lung cancer	0.00054	0.000606	CcSEcCtD
Frovatriptan—Somnolence—Etoposide—lung cancer	0.000538	0.000605	CcSEcCtD
Frovatriptan—Insomnia—Paclitaxel—lung cancer	0.000537	0.000603	CcSEcCtD
Frovatriptan—Epistaxis—Methotrexate—lung cancer	0.000536	0.000602	CcSEcCtD
Frovatriptan—Hypersensitivity—Irinotecan—lung cancer	0.000536	0.000602	CcSEcCtD
Frovatriptan—Convulsion—Docetaxel—lung cancer	0.000534	0.0006	CcSEcCtD
Frovatriptan—Paraesthesia—Paclitaxel—lung cancer	0.000533	0.000599	CcSEcCtD
Frovatriptan—Dyspnoea—Paclitaxel—lung cancer	0.000529	0.000594	CcSEcCtD
Frovatriptan—Somnolence—Paclitaxel—lung cancer	0.000528	0.000593	CcSEcCtD
Frovatriptan—Decreased appetite—Etoposide—lung cancer	0.000526	0.000591	CcSEcCtD
Frovatriptan—Myalgia—Docetaxel—lung cancer	0.000525	0.00059	CcSEcCtD
Frovatriptan—Arthralgia—Docetaxel—lung cancer	0.000525	0.00059	CcSEcCtD
Frovatriptan—Chest pain—Docetaxel—lung cancer	0.000525	0.00059	CcSEcCtD
Frovatriptan—Nausea—Vinorelbine—lung cancer	0.000524	0.000589	CcSEcCtD
Frovatriptan—Dyspepsia—Paclitaxel—lung cancer	0.000523	0.000587	CcSEcCtD
Frovatriptan—Body temperature increased—Cisplatin—lung cancer	0.000523	0.000587	CcSEcCtD
Frovatriptan—Asthenia—Irinotecan—lung cancer	0.000522	0.000587	CcSEcCtD
Frovatriptan—Fatigue—Etoposide—lung cancer	0.000522	0.000586	CcSEcCtD
Frovatriptan—Constipation—Etoposide—lung cancer	0.000518	0.000581	CcSEcCtD
Frovatriptan—Pain—Etoposide—lung cancer	0.000518	0.000581	CcSEcCtD
Frovatriptan—Decreased appetite—Paclitaxel—lung cancer	0.000516	0.00058	CcSEcCtD
Frovatriptan—Dry mouth—Docetaxel—lung cancer	0.000513	0.000577	CcSEcCtD
Frovatriptan—Haemoglobin—Methotrexate—lung cancer	0.000513	0.000576	CcSEcCtD
Frovatriptan—Fatigue—Paclitaxel—lung cancer	0.000512	0.000575	CcSEcCtD
Frovatriptan—Haemorrhage—Methotrexate—lung cancer	0.000511	0.000573	CcSEcCtD
Frovatriptan—Pollakiuria—Doxorubicin—lung cancer	0.00051	0.000573	CcSEcCtD
Frovatriptan—Asthenia—Gemcitabine—lung cancer	0.000509	0.000571	CcSEcCtD
Frovatriptan—Pain—Paclitaxel—lung cancer	0.000508	0.00057	CcSEcCtD
Frovatriptan—Constipation—Paclitaxel—lung cancer	0.000508	0.00057	CcSEcCtD
Frovatriptan—Confusional state—Docetaxel—lung cancer	0.000507	0.00057	CcSEcCtD
Frovatriptan—Pharyngitis—Methotrexate—lung cancer	0.000507	0.000569	CcSEcCtD
Frovatriptan—Urinary tract disorder—Methotrexate—lung cancer	0.000504	0.000566	CcSEcCtD
Frovatriptan—Anaphylactic shock—Docetaxel—lung cancer	0.000503	0.000565	CcSEcCtD
Frovatriptan—Pruritus—Gemcitabine—lung cancer	0.000502	0.000563	CcSEcCtD
Frovatriptan—Urethral disorder—Methotrexate—lung cancer	0.0005	0.000562	CcSEcCtD
Frovatriptan—Feeling abnormal—Etoposide—lung cancer	0.000499	0.00056	CcSEcCtD
Frovatriptan—Diarrhoea—Irinotecan—lung cancer	0.000498	0.000559	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Etoposide—lung cancer	0.000495	0.000556	CcSEcCtD
Frovatriptan—Shock—Docetaxel—lung cancer	0.000495	0.000556	CcSEcCtD
Frovatriptan—Visual impairment—Methotrexate—lung cancer	0.000492	0.000552	CcSEcCtD
Frovatriptan—Tachycardia—Docetaxel—lung cancer	0.000491	0.000552	CcSEcCtD
Frovatriptan—Feeling abnormal—Paclitaxel—lung cancer	0.000489	0.000549	CcSEcCtD
Frovatriptan—Hypersensitivity—Cisplatin—lung cancer	0.000487	0.000547	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Paclitaxel—lung cancer	0.000486	0.000545	CcSEcCtD
Frovatriptan—Diarrhoea—Gemcitabine—lung cancer	0.000485	0.000545	CcSEcCtD
Frovatriptan—Dizziness—Irinotecan—lung cancer	0.000481	0.000541	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—lung cancer	0.00048	0.000539	CcSEcCtD
Frovatriptan—Anorexia—Docetaxel—lung cancer	0.00048	0.000539	CcSEcCtD
Frovatriptan—Abdominal pain—Etoposide—lung cancer	0.000479	0.000538	CcSEcCtD
Frovatriptan—Body temperature increased—Etoposide—lung cancer	0.000479	0.000538	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—lung cancer	0.000479	0.000538	CcSEcCtD
Frovatriptan—Tinnitus—Methotrexate—lung cancer	0.000476	0.000535	CcSEcCtD
Frovatriptan—Asthenia—Cisplatin—lung cancer	0.000474	0.000533	CcSEcCtD
Frovatriptan—Abdominal pain—Paclitaxel—lung cancer	0.000469	0.000527	CcSEcCtD
Frovatriptan—Body temperature increased—Paclitaxel—lung cancer	0.000469	0.000527	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—lung cancer	0.000464	0.000522	CcSEcCtD
Frovatriptan—Vomiting—Irinotecan—lung cancer	0.000463	0.00052	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—lung cancer	0.000462	0.000519	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000459	0.000515	CcSEcCtD
Frovatriptan—Chills—Methotrexate—lung cancer	0.000458	0.000514	CcSEcCtD
Frovatriptan—Headache—Irinotecan—lung cancer	0.000456	0.000512	CcSEcCtD
Frovatriptan—Insomnia—Docetaxel—lung cancer	0.000455	0.000511	CcSEcCtD
Frovatriptan—Diarrhoea—Cisplatin—lung cancer	0.000452	0.000508	CcSEcCtD
Frovatriptan—Paraesthesia—Docetaxel—lung cancer	0.000452	0.000507	CcSEcCtD
Frovatriptan—Vomiting—Gemcitabine—lung cancer	0.000451	0.000506	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—lung cancer	0.00045	0.000505	CcSEcCtD
Frovatriptan—Dyspnoea—Docetaxel—lung cancer	0.000449	0.000504	CcSEcCtD
Frovatriptan—Somnolence—Docetaxel—lung cancer	0.000447	0.000502	CcSEcCtD
Frovatriptan—Mental disorder—Methotrexate—lung cancer	0.000447	0.000502	CcSEcCtD
Frovatriptan—Hypersensitivity—Etoposide—lung cancer	0.000446	0.000501	CcSEcCtD
Frovatriptan—Malnutrition—Methotrexate—lung cancer	0.000444	0.000499	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—lung cancer	0.000444	0.000499	CcSEcCtD
Frovatriptan—Headache—Gemcitabine—lung cancer	0.000444	0.000499	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—lung cancer	0.000443	0.000498	CcSEcCtD
Frovatriptan—Dyspepsia—Docetaxel—lung cancer	0.000443	0.000497	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—lung cancer	0.000442	0.000496	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—lung cancer	0.00044	0.000494	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—lung cancer	0.000439	0.000493	CcSEcCtD
Frovatriptan—Decreased appetite—Docetaxel—lung cancer	0.000437	0.000491	CcSEcCtD
Frovatriptan—Hypersensitivity—Paclitaxel—lung cancer	0.000437	0.000491	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—lung cancer	0.000437	0.00049	CcSEcCtD
Frovatriptan—Dysgeusia—Methotrexate—lung cancer	0.000435	0.000489	CcSEcCtD
Frovatriptan—Asthenia—Etoposide—lung cancer	0.000434	0.000488	CcSEcCtD
Frovatriptan—Fatigue—Docetaxel—lung cancer	0.000434	0.000487	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—lung cancer	0.000433	0.000487	CcSEcCtD
Frovatriptan—Nausea—Irinotecan—lung cancer	0.000432	0.000486	CcSEcCtD
Frovatriptan—Pain—Docetaxel—lung cancer	0.00043	0.000483	CcSEcCtD
Frovatriptan—Constipation—Docetaxel—lung cancer	0.00043	0.000483	CcSEcCtD
Frovatriptan—Back pain—Methotrexate—lung cancer	0.00043	0.000483	CcSEcCtD
Frovatriptan—Pruritus—Etoposide—lung cancer	0.000428	0.000481	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—lung cancer	0.000426	0.000478	CcSEcCtD
Frovatriptan—Asthenia—Paclitaxel—lung cancer	0.000426	0.000478	CcSEcCtD
Frovatriptan—Nausea—Gemcitabine—lung cancer	0.000421	0.000473	CcSEcCtD
Frovatriptan—Vomiting—Cisplatin—lung cancer	0.00042	0.000472	CcSEcCtD
Frovatriptan—Pruritus—Paclitaxel—lung cancer	0.00042	0.000472	CcSEcCtD
Frovatriptan—Feeling abnormal—Docetaxel—lung cancer	0.000415	0.000466	CcSEcCtD
Frovatriptan—Diarrhoea—Etoposide—lung cancer	0.000414	0.000465	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methotrexate—lung cancer	0.000412	0.000463	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—lung cancer	0.000412	0.000463	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Docetaxel—lung cancer	0.000412	0.000462	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—lung cancer	0.00041	0.000461	CcSEcCtD
Frovatriptan—Diarrhoea—Paclitaxel—lung cancer	0.000406	0.000456	CcSEcCtD
Frovatriptan—Malaise—Methotrexate—lung cancer	0.000401	0.00045	CcSEcCtD
Frovatriptan—Dizziness—Etoposide—lung cancer	0.0004	0.00045	CcSEcCtD
Frovatriptan—Vertigo—Methotrexate—lung cancer	0.000399	0.000448	CcSEcCtD
Frovatriptan—Body temperature increased—Docetaxel—lung cancer	0.000398	0.000447	CcSEcCtD
Frovatriptan—Abdominal pain—Docetaxel—lung cancer	0.000398	0.000447	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—lung cancer	0.000397	0.000445	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—lung cancer	0.000395	0.000443	CcSEcCtD
Frovatriptan—Dizziness—Paclitaxel—lung cancer	0.000393	0.000441	CcSEcCtD
Frovatriptan—Nausea—Cisplatin—lung cancer	0.000393	0.000441	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—lung cancer	0.000387	0.000435	CcSEcCtD
Frovatriptan—Convulsion—Methotrexate—lung cancer	0.000385	0.000432	CcSEcCtD
Frovatriptan—Vomiting—Etoposide—lung cancer	0.000385	0.000432	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—lung cancer	0.000385	0.000432	CcSEcCtD
Frovatriptan—Headache—Etoposide—lung cancer	0.000379	0.000426	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—lung cancer	0.000379	0.000426	CcSEcCtD
Frovatriptan—Arthralgia—Methotrexate—lung cancer	0.000378	0.000425	CcSEcCtD
Frovatriptan—Chest pain—Methotrexate—lung cancer	0.000378	0.000425	CcSEcCtD
Frovatriptan—Myalgia—Methotrexate—lung cancer	0.000378	0.000425	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—lung cancer	0.000378	0.000424	CcSEcCtD
Frovatriptan—Vomiting—Paclitaxel—lung cancer	0.000378	0.000424	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—lung cancer	0.000377	0.000423	CcSEcCtD
Frovatriptan—Discomfort—Methotrexate—lung cancer	0.000374	0.00042	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—lung cancer	0.000374	0.00042	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—lung cancer	0.000372	0.000418	CcSEcCtD
Frovatriptan—Headache—Paclitaxel—lung cancer	0.000372	0.000418	CcSEcCtD
Frovatriptan—Hypersensitivity—Docetaxel—lung cancer	0.000371	0.000416	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—lung cancer	0.00037	0.000415	CcSEcCtD
Frovatriptan—Confusional state—Methotrexate—lung cancer	0.000366	0.000411	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methotrexate—lung cancer	0.000363	0.000407	CcSEcCtD
Frovatriptan—Asthenia—Docetaxel—lung cancer	0.000361	0.000405	CcSEcCtD
Frovatriptan—Nausea—Etoposide—lung cancer	0.00036	0.000404	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—lung cancer	0.000357	0.000401	CcSEcCtD
Frovatriptan—Pruritus—Docetaxel—lung cancer	0.000356	0.0004	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—lung cancer	0.000354	0.000397	CcSEcCtD
Frovatriptan—Nausea—Paclitaxel—lung cancer	0.000353	0.000396	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methotrexate—lung cancer	0.000351	0.000394	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—lung cancer	0.000347	0.00039	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—lung cancer	0.000346	0.000388	CcSEcCtD
Frovatriptan—Anorexia—Methotrexate—lung cancer	0.000346	0.000388	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—lung cancer	0.000345	0.000388	CcSEcCtD
Frovatriptan—Diarrhoea—Docetaxel—lung cancer	0.000344	0.000387	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—lung cancer	0.00034	0.000382	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—lung cancer	0.000338	0.00038	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—lung cancer	0.000333	0.000374	CcSEcCtD
Frovatriptan—Dizziness—Docetaxel—lung cancer	0.000333	0.000374	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00033	0.000371	CcSEcCtD
Frovatriptan—Insomnia—Methotrexate—lung cancer	0.000328	0.000368	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—lung cancer	0.000328	0.000368	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—lung cancer	0.000328	0.000368	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—lung cancer	0.000328	0.000368	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—lung cancer	0.000327	0.000367	CcSEcCtD
Frovatriptan—Paraesthesia—Methotrexate—lung cancer	0.000326	0.000366	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—lung cancer	0.000324	0.000364	CcSEcCtD
Frovatriptan—Dyspnoea—Methotrexate—lung cancer	0.000323	0.000363	CcSEcCtD
Frovatriptan—Somnolence—Methotrexate—lung cancer	0.000322	0.000362	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—lung cancer	0.00032	0.00036	CcSEcCtD
Frovatriptan—Vomiting—Docetaxel—lung cancer	0.00032	0.000359	CcSEcCtD
Frovatriptan—Dyspepsia—Methotrexate—lung cancer	0.000319	0.000359	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—lung cancer	0.000317	0.000356	CcSEcCtD
Frovatriptan—Decreased appetite—Methotrexate—lung cancer	0.000315	0.000354	CcSEcCtD
Frovatriptan—Headache—Docetaxel—lung cancer	0.000315	0.000354	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—lung cancer	0.000314	0.000353	CcSEcCtD
Frovatriptan—Fatigue—Methotrexate—lung cancer	0.000313	0.000351	CcSEcCtD
Frovatriptan—Pain—Methotrexate—lung cancer	0.00031	0.000348	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—lung cancer	0.000309	0.000347	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—lung cancer	0.000307	0.000344	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—lung cancer	0.000304	0.000341	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—lung cancer	0.000299	0.000336	CcSEcCtD
Frovatriptan—Nausea—Docetaxel—lung cancer	0.000299	0.000336	CcSEcCtD
Frovatriptan—Feeling abnormal—Methotrexate—lung cancer	0.000299	0.000336	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methotrexate—lung cancer	0.000297	0.000333	CcSEcCtD
Frovatriptan—Abdominal pain—Methotrexate—lung cancer	0.000287	0.000322	CcSEcCtD
Frovatriptan—Body temperature increased—Methotrexate—lung cancer	0.000287	0.000322	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000286	0.000321	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—lung cancer	0.000284	0.000319	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—lung cancer	0.000282	0.000317	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—lung cancer	0.00028	0.000314	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—lung cancer	0.000279	0.000314	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—lung cancer	0.000276	0.00031	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—lung cancer	0.000273	0.000307	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—lung cancer	0.000271	0.000304	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—lung cancer	0.000269	0.000302	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—lung cancer	0.000269	0.000302	CcSEcCtD
Frovatriptan—Hypersensitivity—Methotrexate—lung cancer	0.000267	0.0003	CcSEcCtD
Frovatriptan—Asthenia—Methotrexate—lung cancer	0.00026	0.000292	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—lung cancer	0.000259	0.000291	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—lung cancer	0.000257	0.000288	CcSEcCtD
Frovatriptan—Pruritus—Methotrexate—lung cancer	0.000257	0.000288	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—lung cancer	0.000248	0.000279	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—lung cancer	0.000248	0.000279	CcSEcCtD
Frovatriptan—Diarrhoea—Methotrexate—lung cancer	0.000248	0.000279	CcSEcCtD
Frovatriptan—Dizziness—Methotrexate—lung cancer	0.00024	0.000269	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—lung cancer	0.000231	0.00026	CcSEcCtD
Frovatriptan—Vomiting—Methotrexate—lung cancer	0.000231	0.000259	CcSEcCtD
Frovatriptan—Headache—Methotrexate—lung cancer	0.000227	0.000255	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—lung cancer	0.000225	0.000253	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—lung cancer	0.000222	0.00025	CcSEcCtD
Frovatriptan—Nausea—Methotrexate—lung cancer	0.000215	0.000242	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—lung cancer	0.000215	0.000241	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—lung cancer	0.000208	0.000233	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—lung cancer	0.0002	0.000224	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—lung cancer	0.000197	0.000221	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—lung cancer	0.000187	0.000209	CcSEcCtD
Frovatriptan—CYP1A2—Metabolism—SDC4—lung cancer	5.32e-05	0.000486	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF9—lung cancer	5.32e-05	0.000486	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HES1—lung cancer	5.29e-05	0.000483	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1R—lung cancer	5.27e-05	0.000482	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCL8—lung cancer	5.25e-05	0.00048	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—RAF1—lung cancer	5.19e-05	0.000474	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HES1—lung cancer	5.18e-05	0.000473	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—POMC—lung cancer	5.17e-05	0.000472	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—IL2—lung cancer	5.12e-05	0.000468	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—JUNB—lung cancer	5.08e-05	0.000464	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—RAF1—lung cancer	5.08e-05	0.000464	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CB—lung cancer	5.07e-05	0.000463	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—IL2—lung cancer	5.02e-05	0.000458	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CB—lung cancer	4.96e-05	0.000453	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CG—lung cancer	4.93e-05	0.000451	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL8—lung cancer	4.87e-05	0.000445	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—RRM1—lung cancer	4.85e-05	0.000443	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTA3—lung cancer	4.85e-05	0.000443	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ERBB3—lung cancer	4.84e-05	0.000442	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CD—lung cancer	4.77e-05	0.000436	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL8—lung cancer	4.77e-05	0.000435	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ERBB3—lung cancer	4.74e-05	0.000433	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—POMC—lung cancer	4.69e-05	0.000429	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL2—lung cancer	4.65e-05	0.000425	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TERT—lung cancer	4.64e-05	0.000423	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STK11—lung cancer	4.61e-05	0.000422	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6R—lung cancer	4.58e-05	0.000418	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—B4GALT5—lung cancer	4.56e-05	0.000416	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL2—lung cancer	4.56e-05	0.000416	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TERT—lung cancer	4.54e-05	0.000415	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGFR1—lung cancer	4.5e-05	0.000411	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FOXO3—lung cancer	4.45e-05	0.000407	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTA4—lung cancer	4.43e-05	0.000405	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HIF1A—lung cancer	4.43e-05	0.000405	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGFR1—lung cancer	4.41e-05	0.000403	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAP2K1—lung cancer	4.36e-05	0.000399	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HIF1A—lung cancer	4.34e-05	0.000397	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CD—lung cancer	4.34e-05	0.000396	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.33e-05	0.000396	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTA2—lung cancer	4.32e-05	0.000395	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOA1—lung cancer	4.28e-05	0.000391	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KDR—lung cancer	4.24e-05	0.000387	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOA1—lung cancer	4.19e-05	0.000383	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AVP—lung cancer	4.17e-05	0.000381	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTA1—lung cancer	4.17e-05	0.000381	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CB—lung cancer	4.16e-05	0.00038	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KDR—lung cancer	4.15e-05	0.000379	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCC3—lung cancer	4.12e-05	0.000377	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1R—lung cancer	4.02e-05	0.000367	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL8—lung cancer	4e-05	0.000365	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKR1C1—lung cancer	3.99e-05	0.000365	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HES1—lung cancer	3.95e-05	0.000361	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APC—lung cancer	3.91e-05	0.000357	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CG—lung cancer	3.91e-05	0.000357	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KIT—lung cancer	3.91e-05	0.000357	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—NRAS—lung cancer	3.91e-05	0.000357	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—UGT1A1—lung cancer	3.88e-05	0.000354	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—RAF1—lung cancer	3.87e-05	0.000354	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGF—lung cancer	3.86e-05	0.000353	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CG—lung cancer	3.82e-05	0.000349	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KIT—lung cancer	3.82e-05	0.000349	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APC—lung cancer	3.82e-05	0.000349	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—NRAS—lung cancer	3.82e-05	0.000349	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—IL2—lung cancer	3.82e-05	0.000349	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGF—lung cancer	3.78e-05	0.000345	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CB—lung cancer	3.78e-05	0.000345	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MAPK3—lung cancer	3.74e-05	0.000342	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GNG11—lung cancer	3.74e-05	0.000341	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.72e-05	0.00034	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—POMC—lung cancer	3.72e-05	0.00034	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—BRAF—lung cancer	3.67e-05	0.000335	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MAPK3—lung cancer	3.66e-05	0.000335	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—POMC—lung cancer	3.64e-05	0.000333	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL8—lung cancer	3.63e-05	0.000332	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6R—lung cancer	3.63e-05	0.000331	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CREBBP—lung cancer	3.62e-05	0.000331	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ERBB3—lung cancer	3.61e-05	0.00033	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—BRAF—lung cancer	3.59e-05	0.000328	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EGFR—lung cancer	3.56e-05	0.000325	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDOA—lung cancer	3.56e-05	0.000325	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6R—lung cancer	3.55e-05	0.000324	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CREBBP—lung cancer	3.55e-05	0.000324	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EGFR—lung cancer	3.48e-05	0.000318	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL2—lung cancer	3.47e-05	0.000317	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TERT—lung cancer	3.46e-05	0.000316	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAP2K1—lung cancer	3.46e-05	0.000316	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NCOA3—lung cancer	3.45e-05	0.000316	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CD—lung cancer	3.43e-05	0.000314	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CA—lung cancer	3.4e-05	0.000311	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.39e-05	0.00031	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAP2K1—lung cancer	3.38e-05	0.000309	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CD—lung cancer	3.36e-05	0.000307	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—KRAS—lung cancer	3.36e-05	0.000307	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCG2—lung cancer	3.36e-05	0.000307	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADCY1—lung cancer	3.36e-05	0.000307	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGFR1—lung cancer	3.36e-05	0.000307	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CA—lung cancer	3.33e-05	0.000304	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HIF1A—lung cancer	3.31e-05	0.000302	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HPGDS—lung cancer	3.3e-05	0.000301	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ENO2—lung cancer	3.3e-05	0.000301	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—KRAS—lung cancer	3.29e-05	0.000301	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPP2R1B—lung cancer	3.27e-05	0.000299	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.23e-05	0.000295	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTT1—lung cancer	3.2e-05	0.000292	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOA1—lung cancer	3.19e-05	0.000292	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KDR—lung cancer	3.16e-05	0.000289	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2A6—lung cancer	3.16e-05	0.000289	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCLC—lung cancer	3.16e-05	0.000289	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.15e-05	0.000288	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CA—lung cancer	3.09e-05	0.000282	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MDM2—lung cancer	3.08e-05	0.000281	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RAF1—lung cancer	3.07e-05	0.00028	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ERBB2—lung cancer	3.03e-05	0.000277	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CA—lung cancer	3.02e-05	0.000276	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MDM2—lung cancer	3.01e-05	0.000275	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RAF1—lung cancer	3e-05	0.000274	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ENO1—lung cancer	2.99e-05	0.000274	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MTOR—lung cancer	2.99e-05	0.000273	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CB—lung cancer	2.99e-05	0.000273	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.98e-05	0.000273	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ERBB2—lung cancer	2.97e-05	0.000271	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.95e-05	0.000269	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MTOR—lung cancer	2.93e-05	0.000268	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CB—lung cancer	2.93e-05	0.000268	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KIT—lung cancer	2.91e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APC—lung cancer	2.91e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CG—lung cancer	2.91e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—NRAS—lung cancer	2.91e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGF—lung cancer	2.88e-05	0.000263	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL8—lung cancer	2.88e-05	0.000263	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HRAS—lung cancer	2.86e-05	0.000261	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL8—lung cancer	2.82e-05	0.000257	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HRAS—lung cancer	2.8e-05	0.000256	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAPK3—lung cancer	2.79e-05	0.000255	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—lung cancer	2.78e-05	0.000254	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—POMC—lung cancer	2.77e-05	0.000253	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CASP3—lung cancer	2.75e-05	0.000251	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL2—lung cancer	2.75e-05	0.000251	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—BRAF—lung cancer	2.74e-05	0.00025	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—lung cancer	2.73e-05	0.00025	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—lung cancer	2.72e-05	0.000249	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6R—lung cancer	2.71e-05	0.000247	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CREBBP—lung cancer	2.7e-05	0.000247	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CASP3—lung cancer	2.7e-05	0.000246	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL2—lung cancer	2.69e-05	0.000246	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2E1—lung cancer	2.69e-05	0.000245	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCND1—lung cancer	2.68e-05	0.000245	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—lung cancer	2.68e-05	0.000245	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—JUN—lung cancer	2.67e-05	0.000244	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NQO1—lung cancer	2.66e-05	0.000243	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EGFR—lung cancer	2.65e-05	0.000242	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCND1—lung cancer	2.62e-05	0.00024	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—JUN—lung cancer	2.62e-05	0.000239	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—lung cancer	2.6e-05	0.000238	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.6e-05	0.000238	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDKN1A—lung cancer	2.59e-05	0.000237	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTEN—lung cancer	2.59e-05	0.000236	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAP2K1—lung cancer	2.58e-05	0.000236	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.58e-05	0.000235	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CD—lung cancer	2.56e-05	0.000234	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—lung cancer	2.55e-05	0.000233	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDKN1A—lung cancer	2.54e-05	0.000232	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	2.54e-05	0.000232	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTEN—lung cancer	2.53e-05	0.000231	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—lung cancer	2.52e-05	0.00023	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—KRAS—lung cancer	2.51e-05	0.000229	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—lung cancer	2.47e-05	0.000226	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EP300—lung cancer	2.47e-05	0.000225	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EP300—lung cancer	2.41e-05	0.000221	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SRC—lung cancer	2.4e-05	0.000219	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—STK11—lung cancer	2.39e-05	0.000219	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SRC—lung cancer	2.35e-05	0.000215	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—lung cancer	2.34e-05	0.000213	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—STAT3—lung cancer	2.31e-05	0.000211	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NRAS—lung cancer	2.31e-05	0.000211	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	2.3e-05	0.00021	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MDM2—lung cancer	2.29e-05	0.00021	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—lung cancer	2.29e-05	0.000209	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RAF1—lung cancer	2.29e-05	0.000209	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—STAT3—lung cancer	2.26e-05	0.000207	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ERBB2—lung cancer	2.26e-05	0.000207	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NRAS—lung cancer	2.26e-05	0.000206	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.25e-05	0.000205	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MTOR—lung cancer	2.23e-05	0.000204	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CB—lung cancer	2.23e-05	0.000204	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTP1—lung cancer	2.22e-05	0.000202	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK3—lung cancer	2.21e-05	0.000202	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK3—lung cancer	2.16e-05	0.000198	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAT—lung cancer	2.16e-05	0.000197	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MYC—lung cancer	2.15e-05	0.000196	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL8—lung cancer	2.15e-05	0.000196	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.14e-05	0.000196	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HRAS—lung cancer	2.13e-05	0.000195	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MYC—lung cancer	2.1e-05	0.000192	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGFR—lung cancer	2.1e-05	0.000192	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCB1—lung cancer	2.1e-05	0.000192	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—lung cancer	2.07e-05	0.000189	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TYMS—lung cancer	2.06e-05	0.000188	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGFR—lung cancer	2.06e-05	0.000188	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP3—lung cancer	2.05e-05	0.000188	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL2—lung cancer	2.05e-05	0.000187	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—lung cancer	2.04e-05	0.000186	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTM1—lung cancer	2.04e-05	0.000186	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCND1—lung cancer	2e-05	0.000183	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—JUN—lung cancer	1.99e-05	0.000182	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KRAS—lung cancer	1.99e-05	0.000181	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KRAS—lung cancer	1.94e-05	0.000178	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—lung cancer	1.94e-05	0.000177	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN1A—lung cancer	1.93e-05	0.000177	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP1A1—lung cancer	1.93e-05	0.000176	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTEN—lung cancer	1.93e-05	0.000176	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ERCC2—lung cancer	1.91e-05	0.000175	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—lung cancer	1.88e-05	0.000172	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EP300—lung cancer	1.84e-05	0.000168	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CA—lung cancer	1.82e-05	0.000167	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SRC—lung cancer	1.79e-05	0.000163	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CA—lung cancer	1.79e-05	0.000163	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TP53—lung cancer	1.76e-05	0.000161	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—lung cancer	1.74e-05	0.000159	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TP53—lung cancer	1.73e-05	0.000158	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STAT3—lung cancer	1.73e-05	0.000158	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NRAS—lung cancer	1.72e-05	0.000157	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HRAS—lung cancer	1.69e-05	0.000154	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA1—lung cancer	1.66e-05	0.000151	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HRAS—lung cancer	1.65e-05	0.000151	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.65e-05	0.000151	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—lung cancer	1.62e-05	0.000148	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MYC—lung cancer	1.6e-05	0.000146	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.59e-05	0.000145	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—lung cancer	1.58e-05	0.000145	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGFR—lung cancer	1.57e-05	0.000143	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CG—lung cancer	1.51e-05	0.000138	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—lung cancer	1.49e-05	0.000136	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KRAS—lung cancer	1.48e-05	0.000135	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—lung cancer	1.46e-05	0.000133	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—POMC—lung cancer	1.44e-05	0.000131	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CREBBP—lung cancer	1.4e-05	0.000128	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.36e-05	0.000124	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CD—lung cancer	1.33e-05	0.000121	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TP53—lung cancer	1.32e-05	0.00012	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—lung cancer	1.31e-05	0.00012	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HRAS—lung cancer	1.26e-05	0.000115	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—lung cancer	1.21e-05	0.00011	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CB—lung cancer	1.16e-05	0.000106	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—lung cancer	1.15e-05	0.000105	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—lung cancer	1.11e-05	0.000102	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTEN—lung cancer	1e-05	9.14e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—EP300—lung cancer	9.55e-06	8.72e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CA—lung cancer	7.06e-06	6.45e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—lung cancer	5.77e-06	5.27e-05	CbGpPWpGaD
